1,074
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The impact of prediabetes and diabetes on endothelial function in a large population-based cohort

ORCID Icon, , ORCID Icon, & ORCID Icon
Article: 2298309 | Received 10 Nov 2023, Accepted 17 Dec 2023, Published online: 07 Jan 2024

References

  • Cavallari I, Bhatt DL, Steg PG, et al. Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial. J Am Coll Cardiol 2021; 77: 1–8. 2021/04/10. doi: 10.1016/j.jacc.2021.02.030.
  • Leon BM and Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 2015; 6: 1246–1258. 2015/10/16. doi: 10.4239/wjd.v6.i13.1246.
  • Kadl A and Leitinger N. The role of endothelial cells in the resolution of acute inflammation. Antioxid Redox Signal 2005; 7: 1744–1754. 2005/12/17. doi: 10.1089/ars.2005.7.1744.
  • Gimbrone MA, Jr.and Garcia-Cardena G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res 2016; 118: 620–636. 2016/02/20. doi: 10.1161/CIRCRESAHA.115.306301.
  • van Hinsbergh VW. Endothelium–role in regulation of coagulation and inflammation. Semin Immunopathol 2012; 34: 93–106. 2011/08/17. doi: 10.1007/s00281-011-0285-5.
  • Caballero AE. Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease. Obesity Research 2003; 11: 1278–1289. doi: 10.1038/oby.2003.174.
  • Calles-Escandon J and Cipolla M. Diabetes and Endothelial Dysfunction: A Clinical Perspective. Endocrine Reviews 2001; 22: 36–52. doi: 10.1210/edrv.22.1.0417.
  • Gupta AK, Ravussin E, Johannsen DL, et al. Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes. Br J Med Med Res 2012; 2: 413–423. doi: 10.9734/bjmmr/2012/1479.
  • Maschirow L, Khalaf K, Al-Aubaidy HA and Jelinek HF. Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes—Biomarkers as a possible tool for early disease detection for rural screening. Clinical Biochemistry 2015; 48: 581–585. doi: 10.1016/j.clinbiochem.2015.02.015
  • Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial Dysfunction Is Detectable in Young Normotensive First-Degree Relatives of Subjects With Type 2 Diabetes in Association With Insulin Resistance. Circulation 2000; 101: 1780–1784. doi: 10.1161/01.CIR.101.15.1780.
  • Steinberg HO, Chaker H, Leaming R, et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. The Journal of Clinical Investigation 1996; 97: 2601–2610. doi: 10.1172/JCI118709.
  • Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 7–17. 2005/01/12. doi: 10.1097/00004872-200501000-00004.
  • Bonetti PO, Pumper GM, Higano ST, et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. Journal of the American College of Cardiology 2004; 44: 2137–2141. doi: 10.1016/j.jacc.2004.08.062.
  • Heffernan KS, Patvardhan EA, Kapur NK, et al. Peripheral augmentation index as a biomarker of vascular aging: an invasive hemodynamics approach. Eur J Appl Physiol 2012; 112: 2871–2879. 2011/12/06. doi: 10.1007/s00421-011-2255-y.
  • Tanaka A, Tomiyama H, Maruhashi T, et al. Physiological Diagnostic Criteria for Vascular Failure. Hypertension 2018; 72: 1060–1071. doi: 10.1161/HYPERTENSIONAHA.118.11554.
  • Koo BK, Chung WY and Moon MK. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study. Cardiovasc Diabetol 2020; 19: 82. 2020/06/15. doi: 10.1186/s12933-020-01062-z.
  • Hahad O, Wild PS, Prochaska JH, et al. Endothelial Function Assessed by Digital Volume Plethysmography Predicts the Development and Progression of Type 2 Diabetes Mellitus. J Am Heart Assoc 2019; 8: e012509. 2019/10/05. doi: 10.1161/JAHA.119.012509.
  • Brunkwall L, Jönsson D, Ericson U, et al. The Malmö Offspring Study (MOS): design, methods and first results. European Journal of Epidemiology 2021; 36: 103–116. doi: 10.1007/s10654-020-00695-4.
  • Manjer J, Carlsson S, Elmstahl S, et al. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001; 10: 489–499. 2002/03/28. doi: 10.1097/00008469-200112000-00003.
  • Jujic A, Kennebäck C, Johansson M, et al. The impact of age on endothelial dysfunction measured by periph­eral arterial tonometry in a healthy population-based cohort - the Malmö offspring study. Blood Press 2023; 32: 2234059. doi: 10.1080/08037051.2023.2234059.
  • Organization WH. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006.
  • Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med 2014; 52: 815–824. doi: 10.1515/cclm-2013-0741.
  • Widlansky ME, Gokce N, Keaney JF, Jr.and Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149–1160. 2003/10/03. doi: 10.1016/s0735-1097(03)00994-x.
  • Hadi HA, Carr CS and Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 2005; 1: 183–198.
  • Sorensen K, Celermajer D, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. The Journal of clinical investigation 1994; 93: 50–55. doi: 10.1172/JCI116983.
  • Gokce N, KeaneyJrJF, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002; 105: 1567–1572. doi: 10.1161/01.cir.0000012543.55874.47.
  • Libby P, Ridker PM and Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1143. doi: 10.1161/hc0902.104353.
  • Sun HJ, Wu ZY, Nie XW and Bian JS. Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide. Front Pharmacol 2019; 10: 1568. 2020/02/11. doi: 10.3389/fphar.2019.01568.
  • Sandoo A, van Zanten JJ, Metsios GS, et al. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010; 4: 302–312. 2011/02/23. doi: 10.2174/1874192401004010302.
  • Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. American heart journal 2003; 146: 168–174. 2003/07/10. doi: 10.1016/S0002-8703(03)00094-2.
  • Bonetti PO, Barsness GW, Keelan PC, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. Journal of the American College of Cardiology 2003; 41: 1761–1768. 2003/05/28. doi: 10.1016/s0735-1097(03)00329-2.
  • Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. European heart journal 2010; 31: 1142–1148. 2010/02/26. doi: 10.1093/eurheartj/ehq010.
  • Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008; 117: 2467–2474. 2008/05/07. doi: 10.1161/CIRCULATIONAHA.107.748574.
  • Sverdlov AL, Ngo DT, Chan WP, et al. Aging of the nitric oxide system: are we as old as our NO? Journal of the American Heart Association 2014; 3 2014/08/20. doi: 10.1161/JAHA.114.000973.
  • Hamburg NM and Benjamin EJ. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med 2009; 19: 6–11. 2009/05/27. doi: 10.1016/j.tcm.2009.03.001.
  • de Jongh RT, Serne EH, RG IJ, et al. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109: 2529–2535. 2004/05/12. doi: 10.1161/01.CIR.0000129772.26647.6F.
  • Frisbee JC. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 2005; 289: R307–R316. 2005/04/02. doi: 10.1152/ajpregu.00114.2005.
  • Phillips SA, Sylvester FA and Frisbee JC. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R522–530. 2004/10/30. doi: 10.1152/ajpregu.00655.2004.
  • Ding Y, Vaziri ND, Coulson R, et al. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 2000; 279: E11–17. doi: 10.1152/ajpendo.2000.279.1.E11.
  • Zúrová-Nedelcevová J, Navarová J, Drábiková K, et al. Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuro Endocrinol Lett 2006; 27 Suppl 2: 168–171.
  • Dhananjayan R, Koundinya KSS, Malati T and Kutala VK. Endothelial Dysfunction in Type 2 Diabetes Mellitus. Indian Journal of Clinical Biochemistry 2016; 31: 372–379. doi: 10.1007/s12291-015-0516-y.
  • Gallo G, Volpe M and Savoia C. Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications. Front Med (Lausanne) 2021; 8: 798958. 20220120. doi: 10.3389/fmed.2021.798958.